Outset Medical (OM) Free Cash Flow Growth (1y) (2020 - 2026)
Outset Medical (OM) Free Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | 133.09% |
| 10 | Outset Medical | 80,014.42 | -286.56 Mn | 12.10 Mn | 49.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.94% |
| Dec 31, 2025 | 37.74% |
| Sep 30, 2025 | 67.59% |
| Jun 30, 2025 | 85.78% |
| Mar 31, 2025 | 43.88% |
| Dec 31, 2024 | 29.55% |
| Sep 30, 2024 | 39.73% |
| Jun 30, 2024 | -16.57% |
| Mar 31, 2024 | -0.84% |
| Dec 31, 2023 | 34.89% |
| Sep 30, 2023 | -10.79% |
| Jun 30, 2023 | 28.59% |
| Mar 31, 2023 | -14.45% |
| Dec 31, 2022 | -1.76% |
| Sep 30, 2022 | -3.62% |
| Jun 30, 2022 | -35.18% |
| Mar 31, 2022 | -0.70% |
| Dec 31, 2021 | -70.04% |
| Sep 30, 2021 | 0.91% |
| Jun 30, 2021 | -40.55% |